Technology | September 29, 2009

Calypso’s GPS for the Body Tracks Tumors

Known as GPS for the Body technology, the Calypso System utilizes miniature implanted Beacon transponders to provide precise, continuous, real-time information about the location of the tumor target during external beam radiation therapy. Any movement by the patient, including internal movement of the tumor, has the potential to compromise treatment accuracy. In contrast to other tumor-targeting solutions, Calypso's GPS for the Body technology provides continuous objective tumor position information, thereby enabling the correct radiation dose to be delivered to the tumor while minimizing the amount of radiation misapplied to normal tissue.

In May 2008 the System was cleared by the FDA for post-prostatectomy patients at risk for or diagnosed with recurrent prostate cancer. Studies indicate up to 20 percent of prostatectomy patients are diagnosed with recurrent prostate cancer following surgery and require adjuvant or salvage radiation therapy.

This technology platform is designed to provide continuous tracking information during external beam radiation therapy without adding ionizing radiation.

For more information: www.calypsomedical.com

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...